RWC 2024: Longitudinal BCVA and safety analysis of mutation-agnostic MCO-010 optogenetic therapy for retinitis ... - modernretina.com

RWC 2024: Longitudinal BCVA and safety analysis of mutation-agnostic MCO-010 optogenetic therapy for retinitis ...  modernretina.com